Key Role of DAMP in Inflammation, Cancer, and Tissue Repair

Clinical Therapeutics

Volumn 38, Issue 5, 2016, Pages 1017-1028

  Pandolfi, Franco ^a   Altamura, Simona ^a   Frosali, Simona ^a   Conti, Pio ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

adenosine triphosphate; ATP; cancer; damage pattern; DAMP; high mobility group box 1; HMGB1; immunology; inflammation

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADVANCED GLYCATION END PRODUCT RECEPTOR; DAMAGE ASSOCIATED MOLECULAR PATTERN PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; PROTEIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; ALARMIN;

AGING; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; ISCHEMIA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SKIN INJURY; TISSUE REPAIR; ANIMAL; MOUSE; NEOPLASM; WOUND HEALING;

ALARMINS; ANIMALS; HUMANS; INFLAMMATION; MICE; NEOPLASMS; WOUND HEALING;

EID: 84961837281     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2016.02.028     Document Type: Review

References (149)

1. E. Venereau, C. Ceriotti, and M.E. Bianchi DAMPs from cell death to new life Front Immunol 6 2015 422
2. M.E. Bianchi, and A. Agresti HMG proteins: dynamic players in gene regulation and differentiation Curr Opin Genet Dev 15 2005 496 506
3. M. Zong, J.D. Bruton, C. Grundtman, and et al. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis Ann Rheum Dis 72 2013 1390 1399
4. L.M. Bellussi, C. Iosif, C. Sarafoleanu, and et al. Are HMGB1 protein expression and secretion markers of upper airways inflammatory diseases? J Biol Regul Homeost Agents 27 2013 791 804
5. G. Manukyan, M. Petrek, Z. Navratilova, and et al. Transcriptional activity of neutrophils exposed to high doses of colchicine: short communication J Biol Regul Homeost Agents 29 2015 125 130
6. P. Scaffidi, T. Misteli, and M.E. Bianchi Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 2002 191 195
7. L. Marseglia, G. D?Angelo, M. Manti, and et al. Visfatin: new marker of oxidative stress in preterm newborns Int J Immunopathol Pharmacol 29 2016 23 29
8. B. Lu, C. Wang, M. Wang, and et al. Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review Expert Rev Clin Immunol 10 2014 713 727
9. M.G. Frank, S. Adhikary, J.L. Sobesky, and et al. The danger-associated molecular pattern HMGB1 mediates the neuroinflammatory effects of methamphetamine Brain Behav Immun 51 2016 99 108
10. C.X. Yang, C.Y. Li, and W. Feng Toll-like receptor 4 genetic variants and prognosis of breast cancer Tissue Antigens 81 2013 221 226
11. S. Frosali, D. Pagliari, G. Gambassi, and et al. How the intricate interaction among Toll-like receptors, microbiota, and intestinal immunity can influence gastrointestinal pathology J Immunol Res 2015 2015 489821
12. M. Gersemann, J. Wehkamp, and E.F. Stange Innate immune dysfunction in inflammatory bowel disease J Intern Med 271 2012 421 428
13. K. Takeda, and S. Akira Toll-like receptors Curr Protoc Immunol 109 2015 14.12.1 14.12.10
14. J. Kato, and C.I. Svensson Role of extracellular damage-associated molecular pattern molecules (DAMPs) as mediators of persistent pain Prog Mol Biol Transl Sci 131 2015 251 279
15. M.L. Gougeon, and M.T. Melki Saidi H. HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells Cell Death Differ 19 2012 96 106
16. P. Nowak, S. Abdurahman, A. Lindkvist, and et al. Impact of HMGB1/TLR ligand complexes on HIV-1 replication: possible role for flagellin during HIV-1 Infection Int J Microbiol 2012 2012 263836
17. M. Troseid, A. Lind, P. Nowak, and et al. Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation Innate Immun 19 2013 290 297
18. A. Gombault, L. Baron, and I. Couillin ATP release and purinergic signaling in NLRP3 inflammasome activation Front Immunol 3 2012 414
19. L. Agostini, F. Martinon, K. Burns, and et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder Immunity 20 2004 319 325
20. C.A. Dinarello Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process Am J Clin Nutr 83 2006 447S 455S
21. J. Huang, Y. Xie, X. Sun, and et al. DAMPs, ageing, and cancer: The 'DAMP Hypothesis' Ageing Res Rev 24 2015 3 16
22. Y. Toki, T. Takenouchi, H. Harada, and et al. Extracellular ATP induces P2X7 receptor activation in mouse Kupffer cells, leading to release of IL-1beta, HMGB1, and PGE2, decreased MHC class I expression and necrotic cell death Biochem Biophys Res Commun 458 2015 771 776
23. I. Martins, Y. Wang, M. Michaud, and et al. Molecular mechanisms of ATP secretion during immunogenic cell death Cell Death Differ 21 2014 79 91
24. D. Tang, R. Kang, H.J. Zeh 3rd, M.T. Lotze, and et al. High-mobility group box 1 and cancer Biochim Biophys Acta 1799 2010 131 140
25. L. Zhuang, W.H. Li, K. Li, and et al. HoxB7 promotes growth and metastasis of lung adenocarcinoma cells through regulation of the TGF-beta/SMAD3 signaling J Biol Regul Homeost Agents 29 2015 601 608
26. R. Kang, Q. Zhang, H.J. Zeh 3rd, and et al. HMGB1 in cancer: good, bad, or both? Clin Cancer Res 19 2013 4046 4057
27. M. Hishii, D. Andrews, L.A. Boyle, and et al. In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites Proc Natl Acad Sci U S A 94 1997 1378 1383
28. Z. Liu, L.D. Falo Jr, and Z. You Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunity J Immunol 187 2011 118 125
29. M. Hishii, J.T. Kurnick, T. Ramirez-Montagut, and et al. Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes Clin Exp Immunol 116 1999 388 394
30. F. Pandolfi, R. Cianci, D. Pagliari, and et al. The immune response to tumors as a tool toward immunotherapy Clin Dev Immunol 2011 2011 894704
31. L. Zhuang, W.H. Li, K. Li, and et al. HoxB7 Promotes growth and metastasis of lung adenocarcinoma cells through regulation od the RGF-beta/ SMAD3 signaling J Biol Regul Homeost Agents 29 2015 601 608
32. M.L. Li, X.F. Wang, Z.J. Tan, and et al. Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis Int J Immunopathol Pharmacol 25 2012 955 965
33. X. Zhang, H. Wang, and J. Wang Expression of HMGB1 and NF-kappaB p65 and its significance in non-small cell lung cancer Contemp Oncol (Pozn) 17 2013 350 355
34. C.B. Zhao, J.M. Bao, Y.J. Lu, and et al. Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer Am J Cancer Res 4 2014 369 377
35. J.M. Brickman, M. Adam, and M. Ptashne Interactions between an HMG-1 protein and members of the Rel family Proc Natl Acad Sci U S A 96 1999 10679 10683
36. A. Taguchi, D.C. Blood, G. del Toro, and et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases Nature 405 2000 354 360
37. B.Q. Cheng, C.Q. Jia, C.T. Liu, and et al. Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma Dig Liver Dis 40 2008 446 452
38. M.L. Brezniceanu, K. Volp, S. Bosser, and et al. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma FASEB J 17 2003 1295 1297
39. D. Das, R.C. Peterson, and W.M. Scovell High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity Mol Endocrinol 18 2004 2616 2632
40. J. Zhang, C. Liu, and R. Hou Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells Chin J Cancer Res 26 2014 658 668
41. S. Jube, Z.S. Rivera, M.E. Bianchi, and et al. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma Cancer Res 72 2012 3290 3301
42. Y.R. Choi, H. Kim, H.J. Kang, and et al. Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation Cancer Res 63 2003 2188 2193
43. H. Kuniyasu, T. Sasaki, T. Sasahira, and et al. Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer Pathobiology 71 2004 129 136
44. H.W. Chung, S. Jang, H. Kim, and et al. Combined targeting of high-mobility group box-1 and interleukin-8 to control micrometastasis potential in gastric cancer Int J Cancer 137 2015 1598 1609
45. W. Wang, H. Zhu, H. Zhang, and et al. Targeting HMGB1 inhibits bladder cancer cells bioactivity by lentivirus-mediated RNA interference Neoplasma 61 2014 638 646
46. H. Yao, Z. Zhang, Z. Xiao, and et al. Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection Lung Cancer 65 2009 41 48
47. E. Malusecka, S. Krzyzowska-Gruca, J. Gawrychowski, and et al. Stress proteins HSP27 and HSP70i predict survival in non-small cell lung carcinoma Anticancer Res 28 2008 501 506
48. H.K. Berrieman, L. Cawkwell, S.L. Okane, and et al. Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-small cell lung cancer Oncol Rep 15 2006 283 286
49. M. Fukata, A. Chen, A.S. Vamadevan, and et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors Gastroenterology 133 2007 1869 1881
50. Y. Goto, T. Arigami, M. Kitago, and et al. Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors Mol Cancer Ther 7 2008 3642 3653
51. AM Piccinini, and K.S. Midwood DAMPening inflammation by modulating TLR signalling Mediators Inflamm 2010 http://dx.doi.org/10.1155/2010/672395
52. J.P. Pradere, D.H. Dapito, and R.F. Schwabe The yin and yang of Toll-like receptors in cancer Oncogene 33 2014 3485 3495
53. S. Pandey, S. Singh, V. Anang, and et al. Pattern recognition receptors in cancer progression and metastasis Cancer Growth Metastasis 8 2015 25 34
54. Y. Sato, Y. Nabeta, T. Tsukahara, and et al. Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma J Immunol 169 2002 1611 1618
55. D.H. Dapito, A. Mencin, G.Y. Gwak, and et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4 Cancer Cell 21 2012 504 516
56. M. Fukata, and M.T. Abreu Role of Toll-like receptors in gastrointestinal malignancies Oncogene 27 2008 234 243
57. A. Ochi, C.S. Graffeo, C.P. Zambirinis, and et al. Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans J Clin Invest 122 2012 4118 4129
58. A. Ochi, A.H. Nguyen, A.S. Bedrosian, and et al. MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells J Exp Med 209 2012 1671 1687
59. S. Kumar Pachathundikandi, S. Brandt, J. Madassery, and et al. Induction of TLR-2 and TLR-5 expression by Helicobacter pylori switches cagPAI-dependent signalling leading to the secretion of IL-8 and TNF-alpha PLoS ONE 6 2011 e19614
60. Y.J. Chang, M.S. Wu, J.T. Lin, and et al. Helicobacter pylori-Induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation J Immunol 175 2005 8242 8252
61. X. Wang, J. Wang, L. Liu, and et al. [Expression and clinical significance of TLR2 in laryngeal carcinoma tissue] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 27 2013 629 632
62. H. Weng, Y. Deng, Y. Xie, and et al. Expression and significance of HMGB1, TLR4 and NF-kappaB p65 in human epidermal tumors BMC Cancer 13 2013 311
63. H. Weng, H. Liu, Y. Deng, and et al. Effects of high mobility group protein box 1 and toll like receptor 4 pathway on warts caused by human papillomavirus Mol Med Rep 10 2014 1765 1771
64. A. Oblak, and R. Jerala Toll-like receptor 4 activation in cancer progression and therapy Clin Dev Immunol 2011 2011 609579
65. Y.H. Zhou, S.J. Liao, D. Li, and et al. TLR4 ligand/H(2)O(2) enhances TGF-beta1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways PLoS ONE 8 2013 e65906
66. X. Yuan, Y. Zhou, W. Wang, and et al. Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production Cell Death Dis 4 2013 e794
67. Y.H. Wang, Y.W. Cao, X.C. Yang, and et al. Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance Asian Pac J Cancer Prev 15 2014 1321 1326
68. T.R. Wang, J.C. Peng, Y.Q. Qiao, and et al. Helicobacter pylori regulates TLR4 and TLR9 during gastric carcinogenesis Int J Clin Exp Pathol 7 2014 6950 6955
69. D. Thuringer, A. Hammann, N. Benikhlef, and et al. Transactivation of the epidermal growth factor receptor by heat shock protein 90 via Toll-like receptor 4 contributes to the migration of glioblastoma cells J Biol Chem 286 2011 3418 3428
70. C. Rydberg, A. Mansson, R. Uddman, and et al. Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas Immunology 128 2009 e600 e611
71. K. Zhang, B. Zhou, Y. Wang, and et al. The TLR4 gene polymorphisms and susceptibility to cancer: a systematic review and meta-analysis Eur J Cancer 49 2013 946 954
72. W. He, Q. Liu, L. Wang, and et al. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance Mol Immunol 44 2007 2850 2859 http://dx.doi.org/10.1016/j.molimm.2007.01.022
73. J.M. Ehrchen, C. Sunderkotter, D. Foell, and et al. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer J Leukoc Biol 86 2009 557 566
74. L. Campana, F. Santarella, A. Esposito, and et al. Leukocyte HMGB1 is required for vessel remodeling in regenerating muscles J Immunol 192 2014 5257 5264
75. S. Awasthi Toll-like receptor-4 modulation for cancer immunotherapy Front Immunol 5 2014 328
76. A.M. Krieg Toll-free vaccines? Nat Biotechnol 25 2007 303 305
77. D. Musumeci, G.N. Roviello, and D. Montesarchio An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies Pharmacol Ther 141 2014 347 357
78. U. Andersson, and K.J. Tracey HMGB1 is a therapeutic target for sterile inflammation and infection Annu Rev Immunol 29 2011 139 162
79. D. Messmer, H. Yang, G. Telusma, and et al. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization J Immunol 173 2004 307 313
80. M. Pierdominici, F. Mazzetta, E. Caprini, and et al. Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) Clin Exp Immunol 132 2003 323 331
81. F. Pandolfi, R. Cianci, F. Casciano, and et al. Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases J Biol Regul Homeost Agents 25 2011 153 161
82. A.A. Manfredi, A. Capobianco, M.E. Bianchi, and et al. Regulation of dendritic- and T-cell fate by injury-associated endogenous signals Crit Rev Immunol 29 2009 69 86
83. A. Zickert, K. Palmblad, B. Sundelin, and et al. Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis Arthritis Res Ther 14 2012 R36
84. R. Yang, T. Harada, K.P. Mollen, and et al. Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock Mol Med 12 2006 105 114
85. H. Sawa, T. Ueda, Y. Takeyama, and et al. Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis World J Gastroenterol 12 2006 7666 7670
86. J.X. Jiang, M.A. Riquelme, and J.Z. Zhou ATP, a double-edged sword in cancer Oncoscience 2 2015 673 674
87. V. Hlavac, and P. Soucek Role of family D ATP-binding cassette transporters (ABCD) in cancer Biochem Soc Trans 43 2015 937 942
88. W.G. Junger Immune cell regulation by autocrine purinergic signalling Nat Rev Immunol 11 2011 201 212
89. K. Tanaka, J. Choi, Y. Cao, and et al. Extracellular ATP acts as a damage-associated molecular pattern (DAMP) signal in plants Front Plant Sci 5 2014 446
90. A.D. Garg, A.M. Dudek-Peric, E. Romano, and et al. Immunogenic cell death Int J Dev Biol 59 2015 131 140
91. A.D. Garg, D.V. Krysko, T. Verfaillie, and et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death EMBO J 31 2012 1062 1079
92. H.K. Eltzschig, M.V. Sitkovsky, and S.C. Robson Purinergic signaling during inflammation N Engl J Med 367 2012 2322 2333
93. M. Idzko, D. Ferrari, and H.K. Eltzschig Nucleotide signalling during inflammation Nature 509 2014 310 317
94. D.W. Zhang, H. Qiu, Y.M. Mei, and et al. Repair effects of umbilical cord mesenchymal stem cells on podocyte damage of IgA nephropathy J Biol Regul Homeost Agents 29 2015 609 617
95. E. Ranzato, M. Patrone, M. Pedrazzi, and et al. HMGb1 promotes scratch wound closure of HaCaT keratinocytes via ERK1/2 activation Mol Cell Biochem 332 2009 199 205
96. R. Palumbo, M. Sampaolesi, F. De Marchis, and et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation J Cell Biol 164 2004 441 449
97. B. Degryse, T. Bonaldi, P. Scaffidi, and et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells J Cell Biol 152 2001 1197 1206
98. S. Mitola, M. Belleri, C. Urbinati, and et al. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine J Immunol 176 2006 12 15
99. Q. Zhang, S. OHearn, S.L. Kavalukas, and et al. Role of high mobility group box 1 (HMGB1) in wound healing J Surg Res 176 2012 343 347
100. R. Pullerits, I.M. Jonsson, M. Verdrengh, and et al. High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis Arthritis Rheum 48 2003 1693 1700
101. P.S. Yang, D.H. Kim, Y.J. Lee, and et al. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats Respir Res 15 2014 148
102. E. Chavakis, A. Hain, M. Vinci, and et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells Circ Res 100 2007 204 212
103. B.E. Della, M. Tschon, C. Stagni, and et al. Biophysical Stimulation for Nonunions J Biol Regul Homeost Agents 29 2015 25 38
104. C. Lei, S. Zhang, T. Cao, and et al. HMGB1 may act via RAGE to promote angiogenesis in the later phase after intracerebral hemorrhage Neuroscience 295 2015 39 47
105. Q. Lin, X.P. Yang, D. Fang, and et al. High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis Arterioscler Thromb Vasc Biol 31 2011 1024 1032
106. J.R. van Beijnum, R.P. Dings, E. van der Linden, and et al. Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature Blood 108 2006 2339 2348
107. J.R. van Beijnum, P. Nowak-Sliwinska, E. van den Boezem, and et al. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1 Oncogene 32 2013 363 374
108. S. Nucera, D. Biziato, and M. De Palma The interplay between macrophages and angiogenesis in development, tissue injury and regeneration Int J Dev Biol 55 2011 495 503
109. A. Fantin, J.M. Vieira, G. Gestri, and et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction Blood 116 2010 829 840
110. G.P. Sims, D.C. Rowe, S.T. Rietdijk, and et al. HMGB1 and RAGE in inflammation and cancer Annu Rev Immunol 28 2010 367 388
111. F. Biscetti, G. Straface, R. De Cristofaro, and et al. High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism Diabetes 59 2010 1496 1505
112. U. Sachdev, X. Cui, and E. Tzeng HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia J Vasc Surg 58 2013 460 469
113. S. Straino, A. Di Carlo, A. Mangoni, and et al. High-mobility group box 1 protein in human and murine skin: involvement in wound healing J Invest Dermatol 128 2008 1545 1553
114. S. Muhammad, W. Barakat, S. Stoyanov, and et al. The HMGB1 receptor RAGE mediates ischemic brain damage J Neurosci 28 2008 12023 12031
115. C. Schlueter, H. Weber, B. Meyer, and et al. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule Am J Pathol 166 2005 1259 1263
116. A.J. Singer, and R.A. Clark Cutaneous wound healing N Engl J Med 341 1999 738 746
117. U. Sachdev, X. Cui, G. Hong, and et al. High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury J Vasc Surg 55 2012 180 191
118. A. Tsung, J.R. Klune, X. Zhang, and et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling J Exp Med 204 2007 2913 2923
119. T. Kitahara, Y. Takeishi, M. Harada, and et al. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice Cardiovasc Res 80 2008 40 46
120. N. Yu, L. Erb, R. Shivaji, and et al. Binding of the P2Y2 nucleotide receptor to filamin A regulates migration of vascular smooth muscle cells Circ Res 102 2008 581 588
121. 2+, phospholipase C and mitogen-activated protein kinase Br J Pharmacol 122 1997 935 941
122. C.M. Satterwhite, A.M. Farrelly, and M.E. Bradley Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells Am J Physiol 276 1999 H1091 H1097
123. H. Jin, J. Seo, S.Y. Eun, and et al. P2Y2 R activation by nucleotides promotes skin wound-healing process Exp Dermatol 23 2014 480 485
124. K.S. Ravichandran Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums J Exp Med 207 2010 1807 1817
125. S. Nakagawa, T. Omura, A. Yonezawa, and et al. Extracellular nucleotides from dying cells act as molecular signals to promote wound repair in renal tubular injury Am J Physiol Renal Physiol 307 2014 F1404 F1411
126. E. Gonzales, B. Julien, V. Serriere-Lanneau, and et al. ATP release after partial hepatectomy regulates liver regeneration in the rat J Hepatol 52 2010 54 62
127. A.M. Weihs, C. Fuchs, A.H. Teuschl, and et al. Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation J Biol Chem 289 2014 27090 27104
128. E. Kaczmarek, L. Erb, K. Koziak, and et al. Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways Thromb Haemost 93 2005 735 742
129. L.M. Hill, M.L. Gavala, L.Y. Lenertz, and P.J. Bertics Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes J Immunol 185 2010 3028 3034
130. A.S. MacLeod, R. Rudolph, R. Corriden, and et al. Skin-resident T cells sense ultraviolet radiation-induced injury and contribute to DNA repair J Immunol 192 2014 5695 5702
131. P. Fang, H.C. Pan, S.L. Lin, and et al. HMGB1 contributes to regeneration after spinal cord injury in adult zebrafish Mol Neurobiol 49 2014 472 483
132. K. Tamai, T. Yamazaki, T. Chino, and et al. PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia Proc Natl Acad Sci U S A 108 2011 6609 6614
133. F. Limana, G. Esposito, P. Fasanaro, and et al. Transcriptional profiling of HMGB1-induced myocardial repair identifies a key role for Notch signaling Mol Ther 21 2013 1841 1851
134. R. De Mori, S. Straino, A. Di Carlo, and et al. Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration Arterioscler Thromb Vasc Biol 27 2007 2377 2383
135. G. Sorci, F. Riuzzi, C. Arcuri, and et al. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding Mol Cell Biol 24 2004 4880 4894
136. Y. Luo, H. Ohmori, K. Fujii, and et al. HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer Eur J Cancer 46 2010 791 799
137. S. Maeda, Y. Hikiba, W. Shibata, and et al. Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer Biochem Biophys Res Commun 360 2007 394 400
138. I.D. Kim, J.H. Shin, H.K. Lee, and et al. Intranasal delivery of HMGB1-binding heptamer peptide confers a robust neuroprotection in the postischemic brain Neurosci Lett 525 2012 179 183
139. S. Kim, H.D. Choi, I.D. Kim, and et al. Formation of a polymer particle monolayer by continuous self-assembly from a colloidal solution J Colloid Interface Sci 368 2012 9 13
140. S.W. Kim, Y. Jin, J.H. Shin, and et al. Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion Neurobiol Dis 46 2012 147 156
141. K. Liu, S. Mori, H.K. Takahashi, and et al. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats FASEB J 21 2007 3904 3916
142. H.M. Gao, H. Zhou, F. Zhang, and et al. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration J Neurosci 31 2011 1081 1092
143. S.K. Kritas, A. Saggini, G. Cerulli, and et al. Impact of mast cells on multiple sclerosis: inhibitory effect of natalizumab Int J Immunopathol Pharmacol 27 2014 331 335
144. E. Toniato, E. Spinas, A. Saggini, and et al. Immunomodulatory effects of vitamin D on skin inflammation J Biol Regul Homeost Agents 29 2015 563 567
145. S. Polyzoidis, T. Koletsa, S. Panagiotidou, and et al. Mast cells in meningiomas and brain inflammation J Neuroinflammation 12 2015 170
146. T.C. Theoharides, J.M. Stewart, S. Panagiotidou, and et al. Mast cells, brain inflammation and autism Eur J Pharmacol 2015 http://dx.doi.org/10.1016/j.ejphar.2015.03.086. [Epub ahead of print]
147. R.V. DElia, T.R. Laws, A. Carter, and et al. Targeting the "rising DAMP" during a Francisella tularensis infection Antimicrob Agents Chemother 57 2013 4222 4229
148. J.D. Howard, H. Sarojini, R. Wan, and et al. Rapid granulation tissue regeneration by intracellular ATP delivery - a comparison with Regranex PLoS ONE 9 2014 e91787
149. B.A. Boone, and M.T. Lotze Targeting damage-associated molecular pattern molecules (DAMPs) and DAMP receptors in melanoma Methods Mol Biol 1102 2014 537 552